What is the address of Cabinet de Pédiatrie, Dr MORGENTHAL?

The registered office of Cabinet de Pédiatrie, Dr MORGENTHAL is located at Rue Hullos 101, 4000 Liège.

Is Cabinet de Pédiatrie, Dr MORGENTHAL still active?

Yes. According to the CBE (3 October 2026) Cabinet de Pédiatrie, Dr MORGENTHAL is active, legal situation “Normale toestand”, started on 19 July 2019.

Is Cabinet de Pédiatrie, Dr MORGENTHAL registered on Peppol?

Yes, Cabinet de Pédiatrie, Dr MORGENTHAL is registered on the Peppol network with ID 0208:0730895889.

What is the enterprise number of Cabinet de Pédiatrie, Dr MORGENTHAL?

The enterprise number of Cabinet de Pédiatrie, Dr MORGENTHAL is BE0730895889.

When was Cabinet de Pédiatrie, Dr MORGENTHAL founded?

Cabinet de Pédiatrie, Dr MORGENTHAL was founded on 19 July 2019.

Who are the directors of Cabinet de Pédiatrie, Dr MORGENTHAL?

According to the 2025 annual accounts, the directors of Cabinet de Pédiatrie, Dr MORGENTHAL are: Charline Morgenthal.

Is Cabinet de Pédiatrie, Dr MORGENTHAL a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 19 July 2019; 4 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did Cabinet de Pédiatrie, Dr MORGENTHAL make in 2025?

Cabinet de Pédiatrie, Dr MORGENTHAL posted a profit after taxes of € 40,254 in financial year 2025.

What is the revenue of Cabinet de Pédiatrie, Dr MORGENTHAL?

As a small company, Cabinet de Pédiatrie, Dr MORGENTHAL is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 56,867.

Cabinet de Pédiatrie, Dr MORGENTHAL (Private Limited)

Dossier Cabinet de Pédiatrie, Dr MORGENTHAL, printed on 3 October 2026 from databakkes.be/en/0730895889/cabinet-de-pediatrie-dr-morgenthal. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Cabinet de Pédiatrie, Dr MORGENTHAL from Liège, company number BE0730895889, closed financial year 2025 with a result of € 40,254 after tax. For that financial year Cabinet de Pédiatrie, Dr MORGENTHAL recorded a gross margin of € 56,867 and equity of € 2,500. Compared with financial year 2024, the result moved from € 46,844 to € 40,254. The company is profitable. The company holds a healthy buffer. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on January 23, 2026.

What it is worth Healthy

€ 2,500

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 40,254

▼ 14% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 11,564

▼ 52% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 40,254 paid out

100 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Vehicles and equipment

€ 4,747

▼ 24% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 467

▲ 3% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 4,450

▼ 51% vs 2024

Taxes, VAT and social contributions still to pay.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Revenue	€ 147,517 Revenue 2022: € 147,517 First fiscal year in the series	€ 76,973 Revenue 2023: € 76,973 ▼ 48% vs 2022 (€ 147,517) Unfavourable step	-	-
Gross margin	€ 39,290 Gross margin 2022: € 39,290 First fiscal year in the series	€ 11,519 Gross margin 2023: € 11,519 ▼ 71% vs 2022 (€ 39,290) Unfavourable step	€ 62,732 Gross margin 2024: € 62,732 ▲ € 51,213 vs 2023 (€ 11,519) Favourable step	€ 56,867 Gross margin 2025: € 56,867 ▼ 9% vs 2024 (€ 62,732) Unfavourable step	▼ 9%
Profit after taxes	€ 29,525 Profit after taxes 2022: € 29,525 First fiscal year in the series	€ 5,494 Profit after taxes 2023: € 5,494 ▼ 81% vs 2022 (€ 29,525) Unfavourable step	€ 46,844 Profit after taxes 2024: € 46,844 ▲ € 41,351 vs 2023 (€ 5,494) Favourable step	€ 40,254 Profit after taxes 2025: € 40,254 ▼ 14% vs 2024 (€ 46,844) Unfavourable step	▼ 14%
Equity	€ 30,649 Equity 2022: € 30,649 First fiscal year in the series	€ 2,500 Equity 2023: € 2,500 ▼ 92% vs 2022 (€ 30,649) Unfavourable step	€ 2,500 Equity 2024: € 2,500 Unchanged (€ 2,500) Unchanged	€ 2,500 Equity 2025: € 2,500 Unchanged (€ 2,500) Unchanged
Total debts	€ 16,855 Total debts 2022: € 16,855 First fiscal year in the series	€ 23,359 Total debts 2023: € 23,359 ▲ 39% vs 2022 (€ 16,855) Unfavourable step	€ 57,297 Total debts 2024: € 57,297 ▲ 145% vs 2023 (€ 23,359) Unfavourable step	€ 32,229 Total debts 2025: € 32,229 ▼ 44% vs 2024 (€ 57,297) Favourable step	▼ 44%
Cash	€ 31,390 Cash 2022: € 31,390 First fiscal year in the series	€ 6,898 Cash 2023: € 6,898 ▼ 78% vs 2022 (€ 31,390) Unfavourable step	€ 24,113 Cash 2024: € 24,113 ▲ 250% vs 2023 (€ 6,898) Favourable step	€ 11,564 Cash 2025: € 11,564 ▼ 52% vs 2024 (€ 24,113) Unfavourable step	▼ 52%
Retained profit	€ 28,149 Retained profit 2022: € 28,149 First fiscal year in the series	€ 0 Retained profit 2023: € 0 ▼ 100% vs 2022 (€ 28,149) Unfavourable step	€ 0 Retained profit 2024: € 0 Unchanged (€ 0) Unchanged	€ 0 Retained profit 2025: € 0 Unchanged (€ 0) Unchanged
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 33,642 Dividend 2023: € 33,642 Unchanged (€ 0) Unchanged	€ 46,844 Dividend 2024: € 46,844 ▲ 39% vs 2023 (€ 33,642) Unchanged	€ 40,254 Dividend 2025: € 40,254 ▼ 14% vs 2024 (€ 46,844) Unchanged	▼ 14%
Balance sheet total	€ 47,504 Balance sheet total 2022: € 47,504 First fiscal year in the series	€ 25,859 Balance sheet total 2023: € 25,859 ▼ 46% vs 2022 (€ 47,504) Unchanged	€ 59,797 Balance sheet total 2024: € 59,797 ▲ 131% vs 2023 (€ 25,859) Unchanged	€ 34,729 Balance sheet total 2025: € 34,729 ▼ 42% vs 2024 (€ 59,797) Unchanged	▼ 42%

Key figures of Cabinet de Pédiatrie, Dr MORGENTHAL, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 January 2027.

What happened to Cabinet de Pédiatrie, Dr MORGENTHAL?

What happened at Cabinet de Pédiatrie, Dr MORGENTHAL in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jan 23, 2026 New annual accounts for financial year 2025: profit of € 40,254 (▼ 14% vs 2024). Source: NBB ↗
Jul 19, 2019 New establishment in Liège. KBO
Jul 19, 2019 Start of the company according to the CBE. KBO

In short

From € 29,525 profit in 2022 to € 40,254 profit in 2025.

Paid € 35,562 in corporate taxes since 2022.

Best year ever: 2024, with € 46,844 profit.

Paid out € 120,740 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at Cabinet de Pédiatrie, Dr MORGENTHAL? We notify you, reason included.

Follow Cabinet de Pédiatrie, Dr MORGENTHAL

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Charline Morgenthal

Cabinet de Pédiatrie, Dr MORGENTHAL

Behind Cabinet de Pédiatrie, Dr MORGENTHAL is Charline Morgenthal.

See the full network in the app

Directors

According to the 2025 annual accounts

Charline Morgenthal

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Rue Hullos 101

4000 Liège

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0730.895.889
VAT number: BE 0730.895.889
Registered office: Rue Hullos 101, 4000 Liège
Names & denominations: Cabinet de Pédiatrie, Dr MORGENTHAL
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 19 July 2019
Peppol: Active · Active since 11 Feb 2026

View on CBE Public ↗ Annual accounts (NBB) ↗